|Catherine A. Sazdanoff|
Catherine A. Sazdanoff is the President/ CEO of Sazdanoff Consulting, LLC, providing healthcare strategy and business development advisory services, and is Business Advisor to Strata Oncology, Inc., a precision oncology company, among other clients. She is also a member of the Advisory Board of Neurocern, Inc., a dementia insurtech company, and is a lecturer in the Business of Biotech program at the University of Chicago Graham School for Continuing and Professional Education. She serves on the Faculty Advisory Board of the University of Chicago Graham School and on the External Advisory Board of the Rosalind Franklin University Innovation and Research Park. Ms. Sazdanoff's prior corporate roles include Chief Business Officer at Strata Oncology; a number of global corporate positions with Takeda Pharmaceuticals including VP, Global Business Development, VP/ Head of Corporate Projects, and VP, Corporate Development; and Abbott Laboratories, where she held numerous executive positions covering legal, compliance, and business development. She received a B.A. from the University of Notre Dame and a J.D. from Northwestern University School of Law.